0001628280-21-018595.txt : 20210914 0001628280-21-018595.hdr.sgml : 20210914 20210914171223 ACCESSION NUMBER: 0001628280-21-018595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210910 FILED AS OF DATE: 20210914 DATE AS OF CHANGE: 20210914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huizinga Robert Bindert CENTRAL INDEX KEY: 0001837648 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 211253151 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: BC V8Z7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 BUSINESS PHONE: 250-708-4272 MAIL ADDRESS: STREET 1: #1203-4464 MARKHAM STREET CITY: VICTORIA BC STATE: A1 ZIP: V8Z 7X8 4 1 wf-form4_163165391729313.xml FORM 4 X0306 4 2021-09-10 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001837648 Huizinga Robert Bindert #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8 BRITISH COLUMBIA, CANADA 0 1 0 0 EVP of Research Common Stock 2021-09-10 4 S 0 5000 19.83 D 133592 D Common Stock 2021-09-10 4 S 0 5000 19.76 D 128592 D Common Stock 2021-09-14 4 S 0 22500 21.75 D 106092 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. /s/ Robert Bindert Huizinga 2021-09-14